# AVITA Medical, Inc.: filings

RCEL · Nasdaq · CIK 1762303 · [Healthcare](/sectors/healthcare.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/rcel.md) · [Financials](/companies/rcel/financials.md) · [Filings](/companies/rcel/filings.md) · [Insiders](/companies/rcel/insiders.md)

## Reports and events: 156 filings

Newest first, by EDGAR acceptance time (Eastern). Filter with ?form= one of: `periodic`, `8-K`, `10-K`, `10-Q`, `4`, `proxy`, `13dg`, `all`, or any form this company filed (4 114, 8-K 104, 3 23, 10-Q 18, 6-K 17, UPLOAD 10, CORRESP 7, DEF 14A 7, PRE 14A 7, 10-K 6, 424B5 6, S-8 6, SC 13G 6, 4/A 3, DEFA14A 3, EFFECT 3, S-3 3, SC 13G/A 3, 20FR12B/A 2, 8-K/A 2, ARS 2, D 2, DRS/A 2, DRSLTR 2, SEC STAFF LETTER 2, 10-K/A 1, 10-KT 1, 144 1, 15-12B 1, 20-F 1, 20-F/A 1, 20FR12B 1, 424B2 1, 8-K12B 1, CERT 1, D/A 1, DRS 1, SCHEDULE 13G/A 1, SEC STAFF ACTION 1).

| Filed | Accepted | Form | What it is | Accession |
| --- | --- | --- | --- | --- |
| 2026-08-11 | 16:30 ET | [8-K](/filings/0001193125-26-344787.md) | 1.01 Entry into a material agreement; 9.01 Financial statements and exhibits | 0001193125-26-344787 |
| 2026-08-06 | 16:25 ET | [8-K/A](/filings/0001193125-26-338135.md) | 5.07 Shareholder vote results | 0001193125-26-338135 |
| 2026-08-06 | 16:20 ET | [10-Q](/filings/0001193125-26-338101.md) | Quarterly report, period 2026-06-30 | 0001193125-26-338101 |
| 2026-08-06 | 16:10 ET | [8-K](/filings/0001193125-26-338011.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-26-338011 |
| 2026-06-08 | 19:25 ET | [8-K](/filings/0001762303-26-000011.md) | 1.01 Entry into a material agreement; 9.01 Financial statements and exhibits | 0001762303-26-000011 |
| 2026-06-04 | 19:19 ET | [8-K](/filings/0001762303-26-000003.md) | 5.02 Departure or appointment of officers or directors; 5.07 Shareholder vote results | 0001762303-26-000003 |
| 2026-05-14 | 16:20 ET | [10-Q](/filings/0001193125-26-224107.md) | Quarterly report, period 2026-03-31 | 0001193125-26-224107 |
| 2026-05-14 | 16:10 ET | [8-K](/filings/0001193125-26-224022.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-26-224022 |
| 2026-05-01 | 16:54 ET | [8-K](/filings/0001193125-26-201662.md) | 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-26-201662 |
| 2026-04-22 | 16:30 ET | [DEF 14A](/filings/0001193125-26-170562.md) | Proxy statement, period 2026-04-22 | 0001193125-26-170562 |
| 2026-02-12 | 17:20 ET | [10-K](/filings/0001193125-26-049031.md) | Annual report, period 2025-12-31 | 0001193125-26-049031 |
| 2026-02-12 | 16:15 ET | [8-K](/filings/0001193125-26-048761.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-26-048761 |
| 2026-01-13 | 08:30 ET | [8-K](/filings/0001193125-26-011167.md) | 1.01 Entry into a material agreement; 1.02 Termination of a material agreement; 2.02 Results of operations; 2.03 New direct financial obligation; 3.02 Unregistered sale of equity; 9.01 Financial statements and exhibits | 0001193125-26-011167 |
| 2026-01-05 | 16:10 ET | [8-K](/filings/0001193125-26-002418.md) | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001193125-26-002418 |
| 2025-11-06 | 16:18 ET | [10-Q](/filings/0001193125-25-269597.md) | Quarterly report, period 2025-09-30 | 0001193125-25-269597 |
| 2025-11-06 | 16:12 ET | [8-K](/filings/0001193125-25-269535.md) | 1.01 Entry into a material agreement; 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-25-269535 |
| 2025-10-17 | 19:37 ET | [8-K](/filings/0001193125-25-241705.md) | 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-25-241705 |
| 2025-08-18 | 17:16 ET | [8-K](/filings/0001762303-25-000026.md) | 3.02 Unregistered sale of equity | 0001762303-25-000026 |
| 2025-08-12 | 08:20 ET | [8-K](/filings/0001762303-25-000023.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001762303-25-000023 |
| 2025-08-08 | 19:09 ET | [10-Q](/filings/0001762303-25-000014.md) | Quarterly report, period 2025-06-30 | 0001762303-25-000014 |
| 2025-08-07 | 16:31 ET | [8-K](/filings/0001762303-25-000012.md) | 1.01 Entry into a material agreement; 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001762303-25-000012 |
| 2025-08-06 | 16:10 ET | [8-K](/filings/0000950170-25-104019.md) | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0000950170-25-104019 |
| 2025-06-05 | 19:26 ET | [8-K](/filings/0000950170-25-081880.md) | 5.02 Departure or appointment of officers or directors; 5.07 Shareholder vote results | 0000950170-25-081880 |
| 2025-05-15 | 16:30 ET | [8-K](/filings/0000950170-25-072746.md) | 5.03 Amendment to articles or bylaws; 9.01 Financial statements and exhibits | 0000950170-25-072746 |
| 2025-05-08 | 16:15 ET | [10-Q](/filings/0000950170-25-066994.md) | Quarterly report, period 2025-03-31 | 0000950170-25-066994 |
| 2025-05-08 | 16:05 ET | [8-K](/filings/0000950170-25-066911.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-25-066911 |
| 2025-04-22 | 16:30 ET | [DEF 14A](/filings/0000950170-25-056785.md) | Proxy statement, period 2025-04-22 | 0000950170-25-056785 |
| 2025-03-17 | 16:10 ET | [8-K](/filings/0000950170-25-040249.md) | 1.01 Entry into a material agreement; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0000950170-25-040249 |
| 2025-02-13 | 17:10 ET | [10-K](/filings/0000950170-25-020026.md) | Annual report, period 2024-12-31 | 0000950170-25-020026 |
| 2025-02-13 | 16:05 ET | [8-K](/filings/0000950170-25-019862.md) | 1.01 Entry into a material agreement; 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-25-019862 |
| 2025-01-07 | 16:43 ET | [8-K](/filings/0000950170-25-002907.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-25-002907 |
| 2024-11-07 | 16:10 ET | [10-Q](/filings/0000950170-24-123326.md) | Quarterly report, period 2024-09-30 | 0000950170-24-123326 |
| 2024-11-07 | 16:05 ET | [8-K](/filings/0000950170-24-123279.md) | 2.02 Results of operations; 8.01 Other events; 9.01 Financial statements and exhibits | 0000950170-24-123279 |
| 2024-08-08 | 16:11 ET | [10-Q](/filings/0000950170-24-093964.md) | Quarterly report, period 2024-06-30 | 0000950170-24-093964 |
| 2024-08-08 | 16:09 ET | [8-K](/filings/0000950170-24-093941.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-24-093941 |
| 2024-07-31 | 16:11 ET | [8-K](/filings/0000950170-24-088572.md) | 1.01 Entry into a material agreement; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0000950170-24-088572 |
| 2024-07-01 | 16:36 ET | [8-K](/filings/0000950170-24-079679.md) | 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0000950170-24-079679 |
| 2024-06-06 | 16:39 ET | [8-K](/filings/0000950170-24-069945.md) | 5.02 Departure or appointment of officers or directors; 5.07 Shareholder vote results | 0000950170-24-069945 |
| 2024-05-30 | 16:28 ET | [8-K](/filings/0000950170-24-066656.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0000950170-24-066656 |
| 2024-05-13 | 16:04 ET | [10-Q](/filings/0000950170-24-058619.md) | Quarterly report, period 2024-03-31 | 0000950170-24-058619 |
| 2024-05-13 | 16:02 ET | [8-K](/filings/0000950170-24-058618.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-24-058618 |
| 2024-04-23 | 17:09 ET | [DEF 14A](/filings/0000950170-24-047056.md) | Proxy statement, period 2024-04-23 | 0000950170-24-047056 |
| 2024-04-11 | 17:05 ET | [8-K](/filings/0000950170-24-043776.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-24-043776 |
| 2024-02-22 | 16:05 ET | [10-K](/filings/0000950170-24-018748.md) | Annual report, period 2023-12-31 | 0000950170-24-018748 |
| 2024-02-22 | 16:02 ET | [8-K](/filings/0000950170-24-018735.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-24-018735 |
| 2024-01-10 | 16:05 ET | [8-K](/filings/0000950170-24-003621.md) | 1.01 Entry into a material agreement; 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0000950170-24-003621 |
| 2023-11-09 | 16:09 ET | [8-K](/filings/0000950170-23-062036.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-23-062036 |
| 2023-11-09 | 16:07 ET | [10-Q](/filings/0000950170-23-062024.md) | Quarterly report, period 2023-09-30 | 0000950170-23-062024 |
| 2023-10-23 | 16:36 ET | [8-K](/filings/0000950170-23-054644.md) | 5.02 Departure or appointment of officers or directors | 0000950170-23-054644 |
| 2023-10-18 | 09:07 ET | [8-K](/filings/0000950170-23-053882.md) | 1.01 Entry into a material agreement; 2.02 Results of operations; 2.03 New direct financial obligation; 9.01 Financial statements and exhibits | 0000950170-23-053882 |

Page 1 of 4. [Older](/companies/rcel/filings.md?page=2)
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Oct 24, 2026, 15:15 ET. No prices; not investment advice.